Press Release: Bayer : ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes
Presentations at the American College of Cardiology (ACC) 74th Annual Scientific Session & Expo 2025 include 10 new prespecified subgroup analyses from FINEARTS-HF, the pivotal Phase III cardiovascular (CV) outcomes trial investigating KERENDIA®...
Read full article »
Bayer is a Germany-based holding company that owns and operates businesses in areas such as pharmaceuticals, consumer health and crop protection across the globe.
Read more